U.S. flag

An official website of the United States government

NM_003907.3(EIF2B5):c.584G>A (p.Arg195His) AND Leukoencephalopathy with vanishing white matter 5

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 1, 2002
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003221412.1

Allele description [Variation Report for NM_003907.3(EIF2B5):c.584G>A (p.Arg195His)]

NM_003907.3(EIF2B5):c.584G>A (p.Arg195His)

Gene:
EIF2B5:eukaryotic translation initiation factor 2B subunit epsilon [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q27.1
Genomic location:
Preferred name:
NM_003907.3(EIF2B5):c.584G>A (p.Arg195His)
HGVS:
  • NC_000003.12:g.184137975G>A
  • NG_015826.1:g.7954G>A
  • NM_003907.3:c.584G>AMANE SELECT
  • NP_003898.2:p.Arg195His
  • LRG_1278t1:c.584G>A
  • LRG_1278:g.7954G>A
  • LRG_1278p1:p.Arg195His
  • NC_000003.11:g.183855763G>A
  • NM_003907.2:c.584G>A
  • Q13144:p.Arg195His
Protein change:
R195H; ARG195HIS
Links:
Genetic Testing Registry (GTR): GTR000226533; UniProtKB: Q13144#VAR_016846; OMIM: 603945.0005; dbSNP: rs113994054
NCBI 1000 Genomes Browser:
rs113994054
Molecular consequence:
  • NM_003907.3:c.584G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Leukoencephalopathy with vanishing white matter 5 (VWM5)
Synonyms:
Leukoencephalopathy with vanishing white matter 5, with or without ovarian failure
Identifiers:
MONDO: MONDO:0957873; MedGen: C5779973; OMIM: 620315

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000026492OMIM
no assertion criteria provided
Pathogenic
(Oct 1, 2002)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.

Fogli A, Wong K, Eymard-Pierre E, Wenger J, Bouffard JP, Goldin E, Black DN, Boespflug-Tanguy O, Schiffmann R.

Ann Neurol. 2002 Oct;52(4):506-10.

PubMed [citation]
PMID:
12325082

Details of each submission

From OMIM, SCV000026492.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Fogli et al. (2002) studied the EIF2B5 gene in 3 patients of 2 Cree families with Cree leukoencephalopathy (VWM5; 620315) and identified a homozygous G-to-A transition at nucleotide 584, resulting in an arg195-to-his (R195H) substitution. They reported an unpublished observation of the same R195H mutation in a CACH/VWM family from the Highlands in Scotland. The northern Quebec Cree first encountered Europeans in the early 1700s; these were Scottish fur traders from the Hudson Bay Trading Company. Fogli et al. (2002) stated that the probands from the 2 Cree families in their report could trace their paternal ancestry to 3 English Hudson Bay Company employees around 1770.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024